More ambitious changes may be needed to lower pharmaceutical prices as the Trump administration proposes new rules and approves a slew of new generic drugs.
List view / Grid view
Filter the results
Reforms that have been proposed by the Centers for Medicare and Medicaid Services have sparked comments from officials and companies alike...
PhRMA report highlights the healthy nature of the US biopharmaceuticals industry, which invests about $75bn annually in research and development and supports nearly 4.7m jobs across the country